ATOM vs PFE · rev $135.0K vs P/E 20, rev $62.58B
Atomera Inc (ATOM) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Atomera Inc (ATOM) is a semiconductor equipment & materials company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported ATOM revenue for 2024-12-31 was $135.0K. Net income was -$18.4M. Revenue was down 75.5% from 2023-12-31 to 2024-12-31. ATOM currently screens at market cap $341.1M.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
ATOM currently screens at market cap $341.1M. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the ATOM and PFE stock pages for the full models.
Not investment advice.